Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Nucleic Acids and Circulating Rare Cells: Liquid Biopsy for Early Cancer Detection

Qing Kang's Biography



Qing Kang, Senior Scientist, Syros Pharmaceuticals, Inc.

Qing Kang Image

Abundant, Ultra-Short Trans-Renal Tumor DNA Fragments in Urine For Non-Invasive Cancer Detection and Monitoring

Thursday, 29 March 2018 at 13:00

Add to Calendar ▼2018-03-29 13:00:002018-03-29 14:00:00Europe/LondonAbundant, Ultra-Short Trans-Renal Tumor DNA Fragments in Urine For Non-Invasive Cancer Detection and MonitoringSELECTBIOenquiries@selectbiosciences.com

Circulating tumor DNA (ctDNA) has shown great promise as a cancer biomarker in detecting tumor genotypes, monitoring cancer recurrence and resistance, as well as assessing treatment response. Compared to increased studies in plasma ctDNA, trans-renal tumor DNA (trDNA) exists as a largely untapped field. Here we present a proof-of-concept study to comprehensively understand the fundamentals of trDNA in different cohorts of cancer patients.


Add to Calendar ▼2018-03-28 00:00:002018-03-29 00:00:00Europe/LondonCirculating Nucleic Acids and Circulating Rare Cells: Liquid Biopsy for Early Cancer Detection SELECTBIOenquiries@selectbiosciences.com